Andrej Sali
Corporate Officer/Principal bei The University of California, San Francisco
Profil
Dr. Andrej Sali is Co-Founder at Global Blood Therapeutics, Inc. and a Professor at The University of California, San Francisco.
Dr. Sali was previously employed as an Associate Professor by The Rockefeller University and Founder by Prospect Genomix, Inc.
He received his undergraduate degree from the University of Ljubljana and a doctorate degree from the Birkbeck University of London.
Aktive Positionen von Andrej Sali
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Andrej Sali
| Unternehmen | Position | Ende |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
| Prospect Genomix, Inc. | Gründer | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Andrej Sali
| University of Ljubljana | Undergraduate Degree |
| Birkbeck University of London | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Prospect Genomix, Inc. | |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
